how many people are taking glp 1 drugs Products - Data Briefs - Number 537 Addressing GLP-1 Access and Adherence
Description
Ray JA, Boye KS, Yurgin N, Valentine WJ, Roze S, McKendrick J, Tucker DM, Foos V, Palmer AJ
Current Status of Danuglipron: Phase 2b Trials: As you mentioned, Danuglipron is undergoing clinical trials (Phase 2b) to assess its safety and effectiveness in weight management
2007;105:c62-7
Check out these helpful links for more:Tirzepatide vs
doi: 10.1210/en.2009-1510
An Alternative Low-Cost Option: Kongo If brand-name GLP-1s are out of reachwhether due to cost, insurance restrictions, or accesscompounded medications offer another path forward
